Olugbenga Ogedegbe

Professor of Social and Behavioral Sciences

Professor for the Department of Population Health at NYU Grossman School of Medicine

Professional overview

Gbenga Ogedegbe, a physician, is Professor of Population Health & Medicine, Chief Division of Health & Behavior and Director Center for Healthful Behavior Change in the Department of Population Health at the School of Medicine. Gbenga is a leading expert on health disparities research; his work focuses on the implementation of evidence-based interventions for cardiovascular risk reduction in minority populations. He is Principal Investigator on numerous NIH projects, and has expanded his work globally to Sub-Saharan Africa where he is funded by the NIH to strengthen research capacity and reduce the burden of noncommunicable diseases. He has co-authored over 250 publications and his work has been recognized by receipt of several research and mentoring awards including the prestigious John M. Eisenberg Excellence in Mentorship Award from the Agency for Healthcare Research and Quality, and the Daniel Savage Science Award. He has served on numerous scientific panels including the NIH, CDC, World Health Organization, and the European Union Research Council. Prior to joining NYU, he was faculty at Cornell Weill Medical School and Columbia University College of Physicians and Surgeons. 

Education

MPH from Columbia University, 1999

Residency, Montefiore Medical Center, Internal Medicine, 1998

MD from Donetsk University, 1988

Areas of research and study

Access to Healthcare

Global Health

Health of Marginalized Population

Implementation and Impact of Public Health Regulations

Implementation science

Stroke and Cardiovascular Disease

Publications

Publications

Technology-driven intervention to improve hypertension outcomes in community health centers

The counseling african americans to control hypertension (caatch) trial: Baseline demographic, clinical, psychosocial, and behavioral characteristics

Vitamin D and racial disparity in albuminuria: NHANES 2001-2006

ACP Journal Club. Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension

Cardiovascular disease risk reduction with sleep apnea treatment

Jean-Louis, G., Brown, C. D., Zizi, F., Ogedegbe, G., Boutin-Foster, C., Gorga, J., & McFarlane, S. I. (n.d.).

Publication year

2010

Journal title

Expert Review of Cardiovascular Therapy

Volume

8

Issue

7

Page(s)

995-1005

10.1586/erc.10.55

Abstract

Abstract

Cardiovascular diseases are the leading cause of death among adults in developed countries. An increase in prevalent cardiovascular risk factors (e.g., obesity, hypertension and diabetes) has led to a concerted effort to raise awareness of the need to use evidence-based strategies to help patients at risk of developing cardiovascular disease and to reduce their likelihood of suffering a stroke. Sleep apnea has emerged as an important risk factor for the development of cardiovascular disease. Epidemiologic and clinical evidence has prompted the American Heart Association to issue a scientific statement describing the need to recognize sleep apnea as an important target for therapy in reducing cardiovascular disease risks. This article examines evidence supporting associations of sleep apnea with cardiovascular disease and considers evidence suggesting cardiovascular risk reductions through sleep apnea treatment. Perspectives on emerging therapeutic approaches and promising areas of clinical and experimental research are also discussed.

From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickering's legacy

Masked hypertension: Evidence of the need to treat

Ogedegbe, G., Agyemang, C., & Ravenell, J. E. (n.d.).

Publication year

2010

Journal title

Current Hypertension Reports

Volume

12

Issue

5

Page(s)

349-355

10.1007/s11906-010-0140-4

Abstract

Abstract

The diagnosis of masked hypertension has been made easier with the widespread availability of home blood pressure monitoring devices with levels of accuracy comparable to ambulatory blood pressure monitoring. The negative impact of masked hypertension on cardiovascular morbidity and mortality is evidenced by numerous well-designed clinic-based and population-based studies. The relationship of masked hypertension and target organ damage is also well documented. These two factors, combined with the robust evidence of reduced cardiovascular morbidity and mortality achieved with blood pressure treatment, makes the argument for actively identifying patients with masked hypertension and prescribing treatment similar to that for patients with sustained hypertension. In this paper, we review the evidence for the cardiovascular prognosis of masked hypertension compared with sustained hypertension, we review its impact on target organ damage, we propose an algorithm for the treatment of patients with masked hypertension, and we point out the pitfalls in adopting such an approach.

Measurement of psychiatric treatment adherence

Methodological challenges in psychiatric treatment adherence research

New Recommendations for Treating Hypertension in Black Patients: Evidence and/or Consensus?

Principles and Techniques of Blood Pressure Measurement

Ogedegbe, G., & Pickering, T. (n.d.).

Publication year

2010

Journal title

Cardiology Clinics

Volume

28

Issue

4

Page(s)

571-586

10.1016/j.ccl.2010.07.006

Abstract

Abstract

Although the mercury sphygmomanometer is widely regarded as the gold standard for office blood pressure measurement, the ban on use of mercury devices continues to diminish their role in office and hospital settings. To date, mercury devices have largely been phased out in United States hospitals. This situation has led to the proliferation of nonmercury devices and has changed (probably forever) the preferable modality of blood pressure measurement in clinic and hospital settings. In this article, the basic techniques of blood pressure measurement and the technical issues associated with measurements in clinical practice are discussed. The devices currently available for hospital and clinic measurements and their important sources of error are presented. Practical advice is given on how the different devices and measurement techniques should be used. Blood pressure measurements in different circumstances and in special populations such as infants, children, pregnant women, elderly persons, and obese subjects are discussed.

Sleep duration and the risk of diabetes mellitus: Epidemiologic evidence and pathophysiologic insights

Zizi, F., Jean-Louis, G., Brown, C. D., Ogedegbe, G., Boutin-Foster, C., & McFarlane, S. I. (n.d.).

Publication year

2010

Journal title

Current Diabetes Reports

Volume

10

Issue

1

Page(s)

43-47

10.1007/s11892-009-0082-x

Abstract

Abstract

Evidence from well-defined cohort studies has shown that short sleep, through sleep fragmentation caused by obstructive sleep apnea (OSA) or behavioral sleep curtailment because of lifestyle choices, is associated with increased incidence of diabetes. In this report, we review epidemiologic and clinical data suggesting that OSA is involved in the pathogenesis of altered glucose metabolism. Evidence suggesting increased risk of developing diabetes resulting from curtailed sleep duration is also considered. Proposed mechanisms explaining associations between short sleep and diabetes are examined and clinical management of OSA among patients with diabetes is discussed.

The Epidemiology of Hypertension

Adherence to psychiatric treatments

An overview of cardiovascular risk factor burden in sub-Saharan African countries: A socio-cultural perspective

Applying qualitative methods in developing a culturally tailored workbook for black patients with hypertension

Counseling African Americans to control hypertension (CAATCH) trial: A multi-level intervention to improve blood pressure control in hypertensive blacks

Group visits in the management of diabetes and hypertension: Effect on glycemic and blood pressure control

Loney-Hutchinson, L. M., Provilus, A. D., Jean-Louis, G., Zizi, F., Ogedegbe, O., & McFarlane, S. I. (n.d.).

Publication year

2009

Journal title

Current Diabetes Reports

Volume

9

Issue

3

Page(s)

238-242

10.1007/s11892-009-0038-1

Abstract

Abstract

Diabetes is a major public health problem that is reaching epidemic proportions in the United States and worldwide. Over 22 million Americans currently have diabetes and it is forecast that over 350 million people worldwide will be affected by 2030. Furthermore, the economic cost of diabetes care is enormous. Despite current efforts on the part of health care providers and their patients, outcomes of care remain largely suboptimal, with only 3% to 7% of the entire diabetes population meeting recommended treatment goals for glycemic, blood pressure, and lipid control. Therefore, alternative approaches to diabetes care are desperately needed. Group visits may provide a viable option for patients and health care providers, with the potential to improve outcomes and cost effectiveness. In this review, we highlight the magnitude of the diabetes epidemic, the barriers to optimal diabetes care, and the utility of the concept of group visits as a chronic disease management strategy for diabetes care.

Lifestyle changes and blood pressure control: A community-based cross-sectional survey (2006 Ontario survey on the prevalence and control of hypertension)

Schoenthaler, A., Ravenell, J., Fernandez, S., & Ogedegbe, G. (n.d.). In Journal of Clinical Hypertension (1–).

Publication year

2009

Volume

11

Issue

7

Page(s)

391-392

10.1111/j.1751-7176.2009.00134.x

Obstructive sleep apnea and cardiovascular disease: Evidence and underlying mechanisms

Overweight and obesity among Ghanaian residents in the Netherlands: How do they weigh against their urban and rural counterparts in Ghana?

Predictors of first-fill adherence for patients with hypertension

Provider communication effects medication adherence in hypertensive African Americans

Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans

Schoenthaler, A., Ogedegbe, G., & Allegrante, J. P. (n.d.).

Publication year

2009

Journal title

Health Education and Behavior

Volume

36

Issue

1

Page(s)

127-137

10.1177/1090198107309459

Abstract

Abstract

Many studies have documented the negative effects of depression on adherence to recommended treatment; however, little is known about the mechanism underlying this relationship. Using the Kenny and Baron analytic framework of mediation, the authors assessed whether self-efficacy mediated the relationship between depression and medication adherence in 167 hypertensive African Americans followed in a primary care practice. Depressive symptoms are associated with poor medication adherence (β =.013, p =.036) and low self-efficacy (β = -.008, p =.023). Self-efficacy is negatively associated with medication adherence at follow-up (β = -.612, p <.001). The relationship between depressive symptoms and medication adherence becomes nonsignificant when controlling for self-efficacy (β =.010, p =.087). Implications for further examination into the mediating role of self-efficacy and the deleterious effect of depression on medication adherence are discussed.

Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping